Canine calcium phosphate uroliths.
Uroliths composed primarily of calcium phosphate are identified in approximately 3 per cent of canine stone patients. Predisposing factors to the formation of calcium phosphate uroliths include elevated urine pH, hypercalciuria, and the presence of crystallization inhibitors and promoters. Medical therapy of patients forming calcium phosphate uroliths should initially be directed at removing factors contributing to urine supersaturation with calcium phosphate.
D000141:Acidosis, Renal Tubular / Q000150:complications / Q000188:drug therapy / Q000662:veterinary; D000818:Animals; D002130:Calcium Phosphates / Q000652:urine*; D003460:Crystallization; D004283:Dog Diseases / Q000188:drug therapy / Q000209:etiology* / Q000652:urine; D004285:Dogs; D006863:Hydrogen-Ion Concentration; D006934:Hypercalcemia / Q000150:complications / Q000662:veterinary; D006961:Hyperparathyroidism / Q000150:complications / Q000601:surgery / Q000662:veterinary; D014545:Urinary Calculi / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*
D002130:Calcium Phosphates